Literature DB >> 23843445

Severe hemorrhagic meningoencephalitis due to Angiostrongylus cantonensis among young children in Sydney, Australia.

Nikola J Morton1, Philip Britton, Pamela Palasanthiran, Ann Bye, Ella Sugo, Alison Kesson, Simone Ardern-Holmes, Thomas L Snelling.   

Abstract

Angiostrongylus cantonensis is the most common cause of eosinophilic meningitis worldwide. We describe 2 cases among young children from Sydney, Australia, where locally acquired infection of children has not been reported previously. Both cases manifested as severe hemorrhagic meningoencephalitis, one resulting in death. Angiostrongyliasis must be considered in acute neurological presentations occurring among individuals who live in endemic areas.

Entities:  

Keywords:  Angiostrongylus cantonensis; children; eosinophilia; meningoencephalitis; susceptibility-weighted imaging

Mesh:

Year:  2013        PMID: 23843445     DOI: 10.1093/cid/cit444

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  First Evidence of Angiostrongyliasis Caused by Angiostrongylus cantonensis in Guadeloupe, Lesser Antilles.

Authors:  Céline Dard; Jean-Eudes Piloquet; Yvonne Qvarnstrom; LeAnne M Fox; Helmi M'kada; Jean-Christophe Hebert; Didier Mattera; Dorothée Harrois
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

2.  Case Report: Angiostrongylus cantonensis Infection Presenting as Small Fiber Neuropathy.

Authors:  Johnnie Yates; Todd Devere; Sharin Sakurai-Burton; Brock Santi; Cali McAllister; Kiana Frank
Journal:  Am J Trop Med Hyg       Date:  2022-07-05       Impact factor: 3.707

3.  Neuroangiostrongyliasis: The "Subarachnoid Phase" and Its Implications for Anthelminthic Therapy.

Authors:  Paul Prociv; Megan Turner
Journal:  Am J Trop Med Hyg       Date:  2017-11-30       Impact factor: 2.345

4.  Pilot surveillance for childhood encephalitis in Australia using the Paediatric Active Enhanced Disease Surveillance (PAEDS) network.

Authors:  P N Britton; R C Dale; E Elliott; M Festa; K Macartney; R Booy; C A Jones
Journal:  Epidemiol Infect       Date:  2016-02-26       Impact factor: 4.434

5.  Verminous meningoencephalomyelitis in a red kangaroo associated with Angiostrongylus cantonensis infection.

Authors:  Sonika Patial; Brooke A Delcambre; Peter M DiGeronimo; Gary Conboy; Adriano F Vatta; Rudy Bauer
Journal:  J Vet Diagn Invest       Date:  2021-08-12       Impact factor: 1.569

Review 6.  Species of Angiostrongylus (Nematoda: Metastrongyloidea) in wildlife: A review.

Authors:  David M Spratt
Journal:  Int J Parasitol Parasites Wildl       Date:  2015-03-09       Impact factor: 2.674

7.  The Prevalence of Angiostrongylus cantonensis/mackerrasae Complex in Molluscs from the Sydney Region.

Authors:  Douglas Chan; Joel Barratt; Tamalee Roberts; Rogan Lee; Michael Shea; Deborah Marriott; John Harkness; Richard Malik; Malcolm Jones; Mahdis Aghazadeh; John Ellis; Damien Stark
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

8.  New host, geographic records, and histopathologic studies of Angiostrongylus spp (Nematoda: Angiostrongylidae) in rodents from Argentina with updated summary of records from rodent hosts and host specificity assessment.

Authors:  María del Rosario Robles; John M Kinsella; Carlos Galliari; Graciela T Navone
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03-15       Impact factor: 2.743

9.  The mitochondrial genome of Angiostrongylus mackerrasae as a basis for molecular, epidemiological and population genetic studies.

Authors:  Mahdis Aghazadeh; Rebecca J Traub; Namitha Mohandas; Kieran V Aland; Simon A Reid; James S McCarthy; Malcolm K Jones
Journal:  Parasit Vectors       Date:  2015-09-17       Impact factor: 3.876

10.  A survey of Angiostrongylus species in definitive hosts in Queensland.

Authors:  Mahdis Aghazadeh; Simon A Reid; Kieran V Aland; Angela Cadavid Restrepo; Rebecca J Traub; James S McCarthy; Malcolm K Jones
Journal:  Int J Parasitol Parasites Wildl       Date:  2015-07-14       Impact factor: 2.674

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.